Hyperlipoproteinemia(a) is related to severe coronary and carotid artery diseases in familial hypercholesterolemia patients

Autor: U.V. Chubykina, O.I. Afanasieva, E.A. Klesareva, N.A. Tmoyan, M.V. Ezhov

Publikováno v: Atherosclerosis. 355:55-56

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5c216f6e1222b9ac8d9c5923f096108
https://doi.org/10.1016/j.atherosclerosis.2022.06.393

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease

Autor: Marat V. Ezhov, N.A. Tmoyan, Olga I. Afanasieva, Sergei N. Pokrovsky, E.A. Klesareva, Tatiana V Balakhonova

Publikováno v: Journal of Cardiovascular Development and Disease, Vol 8, Iss 11, p 11 (2021)
Journal of Cardiovascular Development and Disease; Volume 8; Issue 2; Pages: 11
Journal of Cardiovascular Development and Disease

Background and aims: lipoprotein(a) (Lp(a)) is a genetically determined risk factor for coronary artery disease and its complications, although data on the association with other vascular beds and the severity of atherosclerosis is limited. The aim o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ded40d0146da2c06425c5de4bb3cbe4
https://www.mdpi.com/2308-3425/8/2/11

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries

Autor: Olga I. Afanasieva, Sergei N. Pokrovsky, N.A. Tmoyan, M.I. Afanasieva, Marat V. Ezhov

Publikováno v: Biomolecules
Biomolecules, Vol 11, Iss 257, p 257 (2021)
Volume 11
Issue 2

Background: Despite high-intensity lipid-lowering therapy, there is a residual risk of cardiovascular events that could be associated with lipoprotein(a) (Lp(a)). It has been shown that there is an association between elevated Lp(a) level and cardiov

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d1f787a2e9913e2d610dfcc6473b0d
https://pubmed.ncbi.nlm.nih.gov/33578899

[Association of lipoprotein (a) with ischemic stroke and stenotic carotid atherosclerosis]

Autor: M.I. Afanasieva, Marat V. Ezhov, T.V. Balakhonova, Sergei N. Pokrovsky, E.A. Klesareva, N.A. Tmoyan, Olga I. Afanasieva

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 120(3. Vyp. 2)

Lipoprotein(a) [Lp(a)] is a genetically determined risk factor of coronary heart disease and its complications. Meanwhile data about the role of Lp(a) in development of ischemic stroke are controversial.To investigate the association of Lp(a) with at

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1282b6ed25449bc38c4bf93b5a051d6f
https://pubmed.ncbi.nlm.nih.gov/32307429

The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease

Autor: S.N. Pokrovsky, E.A. Klesareva, N.A. Tmoyan, Olga I. Afanasieva, Marat V. Ezhov, Kukharchuk Vv, O. A. Razova

Publikováno v: Терапевтический архив, Vol 90, Iss 9, Pp 31-36 (2018)

Aim. Lipoprotein(a) [Lp(a)] is an independent risk factor of coronary heart disease (CHD) and myocardial infarction. Data about the role of Lp(a) in the development of peripheral artery disease (PAD) is controversial and uncertain. The aim of the stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1a649fb4834cd01df645dd4c60a14ff
https://doi.org/10.26442/terarkh201890931-36